ARCHIVES

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

This article is from The Cancer Letter archive.

Vol. 18 No. 19 | May 8, 1992

Download PDF Visit The Full Archive

Related Articles

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

October 8, 2004

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

November 1, 1991